2-Quinoxalinecarbonitrile - CAS 7483-33-2
Catalog: |
BB035169 |
Product Name: |
2-Quinoxalinecarbonitrile |
CAS: |
7483-33-2 |
Synonyms: |
2-quinoxalinecarbonitrile; quinoxaline-2-carbonitrile |
IUPAC Name: | quinoxaline-2-carbonitrile |
Description: | 2-Quinoxalinecarbonitrile (CAS# 7483-33-2) is a useful research chemical. |
Molecular Weight: | 155.16 |
Molecular Formula: | C9H5N3 |
Canonical SMILES: | C1=CC=C2C(=C1)N=CC(=N2)C#N |
InChI: | InChI=1S/C9H5N3/c10-5-7-6-11-8-3-1-2-4-9(8)12-7/h1-4,6H |
InChI Key: | IVYZWJPQNNZOHV-UHFFFAOYSA-N |
Boiling Point: | 329.7 °C at 760 mmHg |
Density: | 1.29 g/cm3 |
MDL: | MFCD12403337 |
LogP: | 1.50148 |
GHS Hazard Statement: | H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]; H312 (100%): Harmful in contact with skin [Warning Acute toxicity, dermal]; H315 (100%): Causes skin irritation [Warning Skin corrosion/irritation]; H319 (100%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H332 (100%): Harmful if inhaled [Warning Acute toxicity, inhalation]; H335 (100%): May cause respiratory irritation [Warning Specific target organ toxicity, single exposure; Respiratory tract irritation] |
Precautionary Statement: | P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501 |
Signal Word: | Warning |
Publication Number | Title | Priority Date |
CN-113200929-A | Cyanoquinoxaline red-light thermal excitation delayed fluorescent material, and synthesis method and application thereof | 20210401 |
CN-110256342-A | A kind of synthetic method of 2- cyano-quinoline derivatives | 20190716 |
WO-2020040298-A1 | Organic electroluminescent element, display device, illumination device, luminescent layer forming composition, and compound | 20180823 |
WO-2019133633-A1 | Composition including multiple terminally functionalized polymers | 20171230 |
EP-3732210-A1 | Composition including multiple terminally functionalized polymers | 20171230 |
PMID | Publication Date | Title | Journal |
21724395 | 20110801 | New salicylamide and sulfonamide derivatives of quinoxaline 1,4-di-N-oxide with antileishmanial and antimalarial activities | Bioorganic & medicinal chemistry letters |
22084710 | 20110101 | Novel Phenazine 5,10-Dioxides Release OH in Simulated Hypoxia and Induce Reduction of Tumour Volume In Vivo | ISRN pharmacology |
21588729 | 20100825 | Quinoline-2-carbonitrile | Acta crystallographica. Section E, Structure reports online |
21580135 | 20091204 | Quinoxaline-2-carbonitrile | Acta crystallographica. Section E, Structure reports online |
19162490 | 20090215 | Cytotoxic palladium complexes of bioreductive quinoxaline N1,N4-dioxide prodrugs | Bioorganic & medicinal chemistry |
Complexity: | 205 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 155.048347172 |
Formal Charge: | 0 |
Heavy Atom Count: | 12 |
Hydrogen Bond Acceptor Count: | 3 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 155.048347172 |
Rotatable Bond Count: | 0 |
Topological Polar Surface Area: | 49.6 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 1.3 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Quinoxalines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS